Claude Bundrick, MD
Ophthalmology · Shreveport, LANPI 1043538796
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,771 of the $11,502 with a category attached, or 76.3%. It is spread thinly across 31 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Among ophthalmology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $39.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- Rxsight Inc$3K
- AbbVie$1K
- Oyster Point Pharma, Inc.$675
- Biotissue Holdings Inc.$650
- Carl Zeiss Meditec, Inc.$624
- plus $3K from 25 others
Across 7 payments — averaging $3428.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$24K
What the payments were for
- Consulting fees$2,00017%
- Speaking & faculty fees$260%
- Food & beverage$8,77176%
- Gifts$6245%
- Entertainment$811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 76 | $2,607 |
| Rxsight Inc | 14 | $2,504 |
| AbbVie(2 entities) | 55 | $1,005 |
| Oyster Point Pharma, Inc. | 17 | $675 |
| Biotissue Holdings Inc. | 13 | $650 |
| Carl Zeiss Meditec, Inc. | 1 | $624 |
| Glaukos Corporation | 7 | $522 |
| Bausch & Lomb Americas Inc. | 8 | $414 |
| Mallinckrodt Hospital Products Inc. | 12 | $309 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $277 |
| Novartis | 10 | $232 |
| Amgen(2 entities) | 11 | $201 |
| Kala Pharmaceuticals, Inc. | 10 | $184 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $157 |
| Aerie Pharmaceuticals, Inc. | 9 | $154 |
| Sight Sciences, Inc. | 5 | $125 |
| Bausch Health US, LLC | 1 | $102 |
| Staar Surgical Company | 1 | $100 |
| Sun Pharmaceutical Industries Inc. | 5 | $94 |
| Tarsus Pharmaceuticals, Inc. | 3 | $93 |
| Optos, Inc. | 1 | $81 |
| Omeros Corporation | 2 | $71 |
| Thea Pharma Inc. | 3 | $62 |
| Harrow Eye, LLC | 2 | $54 |
| Olympus America Inc. | 1 | $50 |
| Ocular Therapeutix, Inc. | 2 | $33 |
| Axonics, Inc. | 1 | $33 |
| Apellis Pharmaceuticals, Inc. | 1 | $27 |
| Ivantis, Inc | 1 | $26 |
| Shire North American Group Inc | 1 | $18 |
| NEW World Medical,inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$2,282
- RXSIGHT INJECTOR CARTRIDGE$2,282
- RXSIGHT INJECTOR HANDPIECE$2,282
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$2,282
- LIGHT ADJUSTABLE LENS (LAL)$2,282
- IOLMaster$624
- TYRVAYA$325
- ReSTOR$287
- iStent inject Trabecular Micro-Bypass Stent System$168
- iDoseTR$141
- enVista MX60 IOL$128
- AcrySof IQ PanOptix$125
- LenSx$116
- ENVISTA$114
- NGENUITY$101
- IOL$100
How this compares
$11,502 in reported general payments places this provider in the 90th percentile of 286 ophthalmology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 57 | $64,132 |
| Cyclosporine | 47 | $24,793 |
| Prednisolone Acetate | 204 | $9,342 |
| CombiganBrimonidine Tartrate/Timolol | 22 | $8,859 |
| LumiganBimatoprost | 24 | $6,066 |
| Latanoprost | 421 | $4,462 |
| Ketorolac Tromethamine | 152 | $4,117 |
| MoxifloxacinMoxifloxacin Hcl | 180 | $3,270 |
| Brimonidine Tartrate | 15 | $1,596 |
| Difluprednate | 11 | $1,007 |
| Timolol Maleate | 101 | $653 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 20 | $648 |
| ErythromycinErythromycin Base | 46 | $451 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 43 | $424 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 39 | $391 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Combigan, Lumigan | $1,005 | $79,057103 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 286 ophthalmology providers in Louisiana.
Other ophthalmology in Shreveport
- Wyche ColemanShreveport$35K
- Bryan VekoviusShreveport$29K
- Christopher ShelbyShreveport$27K
- Chanping LiangShreveport$15K
- Bryan LuskShreveport$10K
- Arthur KavanaughShreveport$7K
- Ann GuyShreveport$6K
- Jeffrey LuskShreveport$5K
- John CarmodyShreveport$5K
- Blake WilliamsonBaton Rouge$443K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.